Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011,…
| Price | $1.36 |
|---|---|
| Market cap | $59.77M |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Exchange | NASDAQ |
| 52-week range | 1.27-3.4 |
| Beta | 1.61 |
Explore BTMD's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.